A multiple T cell epitope comprising DNA vaccine boosts the protective efficacy of Bacillus Calmette–Guérin (BCG) against Mycobacterium tuberculosis

BACKGROUND: Approximately 80% - 90% of individuals infected with latent Mycobacterium tuberculosis (Mtb) remain protected throughout their life-span. The release of unique, latent-phase antigens are known to have a protective role in the immune response against Mtb. Although the BCG vaccine has been...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:BMC Infect Dis
Main Authors: Maurya, Sudeep Kumar, Aqdas, Mohammad, Das, Deepjyoti Kumar, Singh, Sanpreet, Nadeem, Sajid, Kaur, Gurpreet, Agrewala, Javed Naim
פורמט: Artigo
שפה:Inglês
יצא לאור: BioMed Central 2020
נושאים:
Research Article
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC7495405/
https://ncbi.nlm.nih.gov/pubmed/32942991
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12879-020-05372-1
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים